BMS 599626 is a compound used as an active pharmaceutical ingredient in research. It has been investigated in clinical trials for the study of cancer, metastases, and HER2- or EGFR-expressing advanced solid malignancies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing BMS 599626?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
BMS-599626
pharmaceutical raw material
4-Hydroxy-3,5-diiodopyridine
pharmaceutical raw material
Cephalomannine
pharmaceutical raw material
(RS)-amisulpride
pharmaceutical raw material
(R)-amisulpride
pharmaceutical raw material
[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
LUJZZYWHBDHDQX-QFIPXVFZSA-N
CC1=C2C(=NC=NN2C=C1NC(=O)OC[C@@H]3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F
Sourcing BMS 599626?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.